Midterm Exam Review Plan

The midterm exam will be held from the 22nd to the 24th of this month, covering the entire content of Compulsory Elective Textbook II. Time is tight—only three days are available for review. First, guide students through a general overview of the textbook’s knowledge framework: 1. Civil Rights and Obligations: personal rights, property rights, contracts, and tort liability; 2. Family and Marriage: parent–child relationships, marital property, validity of marriage, support and inheritance; 3. Employment and Entrepreneurship: labor contracts, workers’ rights, social insurance, business operations, and taxation; 4. Resolution of Social Disputes: negotiation / mediation / arbitration / litigation, court procedures, and evidence. Specific review schedule: - In the first class, review Lessons 9 and 10 with students, distinguishing among mediation, arbitration, and litigation—including their differences and classifications. - In the second class, focus on workers’ rights and obligations, as well as channels for rights protection. - In the third class, review inheritance, various civil rights, and tort liability. Additionally, during morning reading time, emphasize the following key points: - Circumstances under which contracts (including labor contracts) are invalid or partially invalid; - Channels for consumer rights protection; - Labor disputes must undergo arbitration before litigation—direct lawsuits are not permitted; - Testamentary succession takes precedence over statutory succession; a legacy-support agreement holds the highest legal effect; - The right to honor ≠ the right to reputation; - Strict liability (no-fault liability): e.g., objects falling from heights, injuries caused by domestic animals, product defects.

Midterm Exam Analysis

I. Analysis of Test Content 1. Fill-in-the-blank questions: Errors were frequent in questions (2), (6), (9), (10), and (11). - Question (2): "The amusement park gate faces north; to enter the gate, walk toward ( )." Students had not encountered similar problems in daily study and thus struggled to apply knowledge flexibly. - Question (6): "The product of 2□ × 2□ is a ( )-digit number." The blanks lacked specific digits, confusing students about how to compute. - Question (9): Estimation—a challenging topic in this textbook. Since estimation may involve overestimating or underestimating, and no fixed standard exists, students found it difficult. - Question (10): A real-life application problem: after baking 22 batches of egg tarts, 3 remain—these 3 require one additional batch. Many students overlooked this final step. - Question (11): Highly challenging—even though it appeared identically on practice tests and was taught and practiced repeatedly, many students still answered incorrectly due to poor comprehension of the question stem. 2. True/False questions: Question 4 proved especially problematic: a modified version of the principle that "the remainder must always be less than the divisor." Students need further practice applying concepts flexibly. 3. Multiple-choice questions: Questions (1), (4), and (5) had high error rates. - Question (1): Among 3□9 ÷ 3, 48□ ÷ 7, and 70□ ÷ 8, which yields the smallest quotient? Similar to Question (6) in the fill-in-the-blank section, students were confused by the blank (□) and missed the keyword "smallest." - Question (4): "There are two watermelon greenhouses. How many watermelons does each greenhouse produce?" Students failed to read carefully and were misled by the phrase "two watermelon greenhouses."

Morning Bid: Midterms and Mediation

Nov 3, 2026

Geopolitical strikes on Iran triggered crude oil price volatility, while tech stocks declined ahead of US midterms. Market attention also focuses on Australian rate hikes and earnings from Pfizer and Amgen.

reuters

2026-02-12

UK Law Firms Eye Legal Action Against Pfizer Over Contraceptive-Linked Brain Tumours

2026-06-10

Pfizer CEO warns German investment at risk over drug pricing policies

2026-06-18

Pfizer CFO Dave Denton to step down, leave company in August

2026-06-23

China Outpacing Europe in Drug Innovation and Development, Pfizer Executive Says

2026-07-10

Polish Air Traffic Control Faces Funding Freeze Over COVID Vaccine Ruling